-
Views
-
Cite
Cite
Bernhard Zöllner, Jörg Petersen, Peter Schäfer, Matthias Schröter, Rainer Laufs, Martina Sterneck, Heinz-Hubert Feucht, Subtype-Dependent Response of Hepatitis B Virus during the Early Phase of Lamivudine Treatment, Clinical Infectious Diseases, Volume 34, Issue 9, 1 May 2002, Pages 1273–1277, https://doi.org/10.1086/339959
- Share Icon Share
Abstract
We conducted a 12-month longitudinal investigation of the subtype-dependent response of hepatitis B virus (HBV) to lamivudine treatment in 43 consecutive patients with chronic hepatitis B. HBV subtype ayw appears to respond better to lamivudine monotherapy than does HBV subtype adw (P = .005). This might be the reason for the lower incidence of lamivudine-resistant strains observed in persons infected with HBV subtype ayw during follow-up.